THE DEAL, AT A GLANCE
From the announcementSwedish biotech AnaCardio
01What happenedSwedish biotech AnaCardio raised Series B, announced 2026-09-29From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Why it mattersSwedish biotech AnaCardio's $70.9M Series B is a material capital-flow signal within the Unclassified funding tape, ranking at the 70th percentile of tracked…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Swedish biotech AnaCardio · Financing Record
Explore source-linked visual explanations for Swedish biotech AnaCardio. Unsupported claims are withheld while source review continues.
Record 13082 · Recorded date: 2026-09-29
Explore company records →